Correlation Between TG Therapeutics and Exelixis
Can any of the company-specific risk be diversified away by investing in both TG Therapeutics and Exelixis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining TG Therapeutics and Exelixis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between TG Therapeutics and Exelixis, you can compare the effects of market volatilities on TG Therapeutics and Exelixis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in TG Therapeutics with a short position of Exelixis. Check out your portfolio center. Please also check ongoing floating volatility patterns of TG Therapeutics and Exelixis.
Diversification Opportunities for TG Therapeutics and Exelixis
0.87 | Correlation Coefficient |
Very poor diversification
The 3 months correlation between TGTX and Exelixis is 0.87. Overlapping area represents the amount of risk that can be diversified away by holding TG Therapeutics and Exelixis in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exelixis and TG Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on TG Therapeutics are associated (or correlated) with Exelixis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exelixis has no effect on the direction of TG Therapeutics i.e., TG Therapeutics and Exelixis go up and down completely randomly.
Pair Corralation between TG Therapeutics and Exelixis
Given the investment horizon of 90 days TG Therapeutics is expected to generate 1.73 times more return on investment than Exelixis. However, TG Therapeutics is 1.73 times more volatile than Exelixis. It trades about 0.19 of its potential returns per unit of risk. Exelixis is currently generating about 0.23 per unit of risk. If you would invest 2,261 in TG Therapeutics on August 31, 2024 and sell it today you would earn a total of 1,239 from holding TG Therapeutics or generate 54.8% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Strong |
Accuracy | 100.0% |
Values | Daily Returns |
TG Therapeutics vs. Exelixis
Performance |
Timeline |
TG Therapeutics |
Exelixis |
TG Therapeutics and Exelixis Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with TG Therapeutics and Exelixis
The main advantage of trading using opposite TG Therapeutics and Exelixis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if TG Therapeutics position performs unexpectedly, Exelixis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exelixis will offset losses from the drop in Exelixis' long position.TG Therapeutics vs. Madrigal Pharmaceuticals | TG Therapeutics vs. Terns Pharmaceuticals | TG Therapeutics vs. Hepion Pharmaceuticals | TG Therapeutics vs. Exelixis |
Exelixis vs. TG Therapeutics | Exelixis vs. Viking Therapeutics | Exelixis vs. Madrigal Pharmaceuticals | Exelixis vs. BioXcel Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Ceiling Movement module to calculate and plot Price Ceiling Movement for different equity instruments.
Other Complementary Tools
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
Fundamental Analysis View fundamental data based on most recent published financial statements | |
CEOs Directory Screen CEOs from public companies around the world |